NL8004361A - Homogeen fibroblasten-interferon en de bereiding daarvan. - Google Patents

Homogeen fibroblasten-interferon en de bereiding daarvan. Download PDF

Info

Publication number
NL8004361A
NL8004361A NL8004361A NL8004361A NL8004361A NL 8004361 A NL8004361 A NL 8004361A NL 8004361 A NL8004361 A NL 8004361A NL 8004361 A NL8004361 A NL 8004361A NL 8004361 A NL8004361 A NL 8004361A
Authority
NL
Netherlands
Prior art keywords
interferon
column
siog
water
human fibroblast
Prior art date
Application number
NL8004361A
Other languages
English (en)
Dutch (nl)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NL8004361A publication Critical patent/NL8004361A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NL8004361A 1979-07-31 1980-07-30 Homogeen fibroblasten-interferon en de bereiding daarvan. NL8004361A (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US6237179A 1979-07-31 1979-07-31
US6237179 1979-07-31
US13063580A 1980-03-14 1980-03-14
US13063580 1980-03-14

Publications (1)

Publication Number Publication Date
NL8004361A true NL8004361A (nl) 1981-02-03

Family

ID=26742182

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8004361A NL8004361A (nl) 1979-07-31 1980-07-30 Homogeen fibroblasten-interferon en de bereiding daarvan.

Country Status (33)

Country Link
US (1) US5015730A (no)
JP (1) JPH02138226A (no)
AR (1) AR229931A1 (no)
AT (1) AT372387B (no)
AU (1) AU536274B2 (no)
CA (1) CA1146468A (no)
CH (1) CH648331A5 (no)
DE (1) DE3028919A1 (no)
DK (1) DK159825C (no)
DO (1) DOP1980002948A (no)
ES (1) ES493849A0 (no)
FI (1) FI70721C (no)
FR (1) FR2462167B1 (no)
GB (1) GB2055384B (no)
HK (1) HK40384A (no)
HU (1) HU185382B (no)
IE (1) IE50075B1 (no)
IL (1) IL60697A (no)
IT (1) IT1132269B (no)
KE (1) KE3364A (no)
LU (1) LU82673A1 (no)
MC (1) MC1337A1 (no)
MY (1) MY8500274A (no)
NL (1) NL8004361A (no)
NO (1) NO151158C (no)
NZ (1) NZ194495A (no)
PH (2) PH17738A (no)
PT (1) PT71625B (no)
RO (1) RO81474B (no)
SE (1) SE466290B (no)
YU (1) YU193480A (no)
ZA (1) ZA803943B (no)
ZW (1) ZW17980A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ196706A (en) 1980-04-03 1988-01-08 Biogen Nv Dna sequences, recombinant dna molecules and processes for producing fibroblast interferon-like polypeptides; pharmaceutical and veterinary compositions
NZ198445A (en) * 1980-09-25 1984-05-31 Genentech Inc Production of human fibroblast interferon by recombinant dna technology
ZA83768B (en) * 1982-03-01 1983-10-26 Hoffmann La Roche Homogeneous human immune interferon and process therefor
US4966843A (en) * 1982-11-01 1990-10-30 Cetus Corporation Expression of interferon genes in Chinese hamster ovary cells
US4569790A (en) * 1984-03-28 1986-02-11 Cetus Corporation Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
US4530787A (en) * 1984-03-28 1985-07-23 Cetus Corporation Controlled oxidation of microbially produced cysteine-containing proteins
US4894330A (en) * 1986-12-23 1990-01-16 Cetus Corporation Purification of recombinant beta-interferon incorporating RP-HPLC
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
US5723125A (en) * 1995-12-28 1998-03-03 Tanox Biosystems, Inc. Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
US20050002902A1 (en) * 1995-12-28 2005-01-06 Liming Yu Hybrid with interferon-alpha and an immunoglobulin Fc for treatment of tumors and viral infections
US20030026779A1 (en) * 1999-10-15 2003-02-06 Liming Yu Treatment of tumors and viral infections with a hybrid conjugate of interferon and an immunoglobulin Fc
LT1917276T (lt) 2005-08-26 2018-05-25 Ares Trading S.A. Glikozilinto interferono beta gavimo būdas
EP1960419B1 (en) 2005-12-09 2016-03-16 Ares Trading S.A. Method for purifying fsh or a fsh mutant
US20100249381A1 (en) * 2007-10-22 2010-09-30 David Delvaille Method for Purifying FC-Fusion Proteins
DE102009032179A1 (de) 2009-07-07 2011-01-13 Biogenerix Ag Verfahren zur Reinigung von Interferon beta

Also Published As

Publication number Publication date
IL60697A0 (en) 1980-09-16
DK159825C (da) 1991-04-29
DK159825B (da) 1990-12-10
DOP1980002948A (es) 1989-04-20
LU82673A1 (fr) 1982-02-17
CH648331A5 (de) 1985-03-15
AU6091480A (en) 1981-02-05
RO81474A (ro) 1983-04-29
GB2055384A (en) 1981-03-04
SE466290B (sv) 1992-01-27
JPH02138226A (ja) 1990-05-28
MC1337A1 (fr) 1981-04-21
RO81474B (ro) 1983-04-30
MY8500274A (en) 1985-12-31
FI70721B (fi) 1986-06-26
SE8005498L (sv) 1981-02-01
ZW17980A1 (en) 1981-03-18
FI802400A (fi) 1981-02-01
US5015730A (en) 1991-05-14
NO151158C (no) 1985-02-20
ZA803943B (en) 1981-06-24
KE3364A (en) 1984-02-03
ATA395080A (de) 1983-02-15
AT372387B (de) 1983-09-26
ES8200560A1 (es) 1981-11-16
DE3028919A1 (de) 1981-02-19
PH18479A (en) 1985-07-18
AU536274B2 (en) 1984-05-03
YU193480A (en) 1984-04-30
HU185382B (en) 1985-01-28
IT1132269B (it) 1986-07-02
ES493849A0 (es) 1981-11-16
AR229931A1 (es) 1984-01-31
NO151158B (no) 1984-11-12
IE50075B1 (en) 1986-02-05
DE3028919C2 (no) 1988-02-18
DK328880A (da) 1981-02-01
IT8023801A0 (it) 1980-07-30
NZ194495A (en) 1984-07-31
PT71625B (en) 1981-12-17
GB2055384B (en) 1983-08-10
CA1146468A (en) 1983-05-17
FR2462167B1 (fr) 1985-07-05
HK40384A (en) 1984-05-18
PT71625A (en) 1980-08-01
FR2462167A1 (fr) 1981-02-13
IE801589L (en) 1981-01-31
IL60697A (en) 1984-04-30
NO802297L (no) 1981-02-02
FI70721C (fi) 1986-10-06
PH17738A (en) 1984-11-23

Similar Documents

Publication Publication Date Title
NL8004361A (nl) Homogeen fibroblasten-interferon en de bereiding daarvan.
US4289689A (en) Preparation of homogeneous human fibroblast interferon
NL193085C (nl) Werkwijze voor de winning van humaan leucocyten-interferon, alsmede farmaceutisch preparaat met het aldus verkregen interferon.
Simpson et al. Rat epidermal growth factor: complete amino acid sequence: Homology with the correspondence murine and human proteins; isolation of a form truncated at both ends with full in vitro biological activity
Said et al. Isolation from porcine‐intestinal wall of a vasoactive octacosapeptide related to secretin and to glucagon
Cutler et al. Purification of a multipotential colony-stimulating factor from pokeweed mitogen-stimulated mouse spleen cell conditioned medium.
Böhlen et al. Human brain fibroblast growth factor: Isolation and partial chemical characterization
EP0131816A1 (en) Modified (1-56) beta interferons
US4765903A (en) Purification of monomeric interferon
GB2119383A (en) Homogeneous human immune interferon and process therefor
BROECKE et al. Characterization of interferon-α binding sites on human cell lines
US4617378A (en) Purification of biologically active human immune interferon
JPH031320B2 (no)
EP0411503A1 (en) Process for identifying and synthesizing binding sites of interacting proteins
WO1995024474A1 (en) Bone morphogenic protein-10
Rubinstein et al. [67] Purification and characterization of human leukocyte interferons by high-performance liquid chromatography
KR840001516B1 (ko) 인체 섬유아세포 인터페론의 제조방법
Körner et al. Simple preparative two-step purification of interleukin-2 from culture medium of lectin stimulated normal human lymphocytes
Yip et al. Isolation of the epidermal growth factor from the shrew submaxillary gland
WO1989003225A1 (en) Purification of monomeric interferon
IE63323B1 (en) Purification of gm-csf
WO1987007617A1 (en) A novel protein, neuroleukin
Smith et al. [26] Purification of multiplication-stimulating activity carrier protein
JPH06263796A (ja) 生理活性ペプチド

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
A85 Still pending on 85-01-01
BB A search report has been drawn up
BC A request for examination has been filed
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: HOFFMANN-LA ROCHE AG. F. -

BV The patent application has lapsed